Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-060895)

Filing Details

Accession Number:: 0001209191-22-060895
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-13 16:00:20
Reporting Period:: 2022-12-09

Accepted Time:: 2022-12-13 16:00:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1681682	Endra Life Sciences Inc.	NDRA	Electromedical & Electrotherapeutic Apparatus (3845)	260579295

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1706297	Milos Michael Thornton	3600 Green Court, Suite 350 Ann Arbor MI 48105	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-09	1,500	$3.40	19,139	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.